Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
04/2004
04/07/2004EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
04/07/2004EP0741731B1 Process for epoxidising prochiral olefins
04/07/2004CN1487929A Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
04/07/2004CN1144809C Method for preparing aloin by extraction
04/06/2004US6716999 Pyrone derivatives and method for producing same
04/06/2004US6716837 Heterocyclic compounds for the treatment of migraine
04/06/2004US6716833 Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
04/06/2004US6716832 Arylphenyl-substituted cyclic ketoenols
04/06/2004CA2067381C Treatment of hiv infections and compounds useful therein
04/01/2004WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
04/01/2004WO2003075853A3 Cyclic derivatives as modulators of chemokine receptor activity
04/01/2004WO2002076402A3 Fatty amine drug conjugates
04/01/2004WO2002053094A8 Method for detoxifying a carbohydrate containing solution
04/01/2004US20040063974 Antidepressants; anxiolytic agents; antiinflammatory agents; analgesics; antiemetics
04/01/2004US20040063685 Cycloalkene antisepsis drug with antibacterial, antifungal, nonsteroidal antiinflammatory, steroid and/or anticoagulant agents
04/01/2004US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases
04/01/2004US20040063669 Alpha-phenyl-beta-ketosulfone
04/01/2004US20040063643 Bombesin antagonists
03/2004
03/31/2004EP1401575A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts
03/31/2004EP1003720B1 Aryloxyarylsulfonylamino hydroxamic acid derivatives
03/31/2004EP0793668B1 Derivatives of carbohydrates and compositions containing them
03/31/2004CN1143853C Preparing method for anti-viral compounds
03/30/2004US6713580 Quaternary amino acids on solid supports
03/30/2004US6713507 Ether compounds and compositions for cholesterol management and related uses
03/25/2004WO2004024687A1 Benzoyl compounds having imino group and herbicides
03/25/2004WO2004024679A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/25/2004WO2003074169A3 Metalorganic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors
03/25/2004WO2003068765A3 Improved process for the production of dihydropyridines
03/25/2004WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists
03/25/2004US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof
03/25/2004US20040059138 Dihydropyrancarboxamides and uses thereof
03/25/2004US20040058937 Heterocyclic mutilin esters and their use as antibacterials
03/25/2004US20040058853 Multivalent neuraminidase inhibitor conjugates
03/25/2004CA2497003A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/24/2004EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders
03/24/2004EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
03/24/2004EP1226194B1 Synthesis of copolymers containing anhydrofructose derivatives
03/24/2004EP0873332B1 Discodermolide compounds and pharmaceutical compositions containing them for cancer therapy
03/24/2004CN1484627A Method and device for the distillative processing of 1.6-hexandiol, 1.5-pentandiol and caprolactone
03/24/2004CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use
03/24/2004CN1142918C Carboxylic acid derivs, their preparation and their use
03/23/2004US6710188 Chemically amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer
03/23/2004CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them
03/18/2004WO2004022552A1 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2003097576A3 Diamino-functional chalcones
03/18/2004WO2003095421A8 Amino acid analogues
03/18/2004WO2003018535A3 Novel aminobenzoephenones
03/18/2004US20040053953 Treatment of chemokine mediated diseases
03/18/2004US20040053158 Onium salts and the use therof as latent acids
03/18/2004US20040053033 Multifunctional monomers and their use in making cross-linked polymers and porous films
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/17/2004EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
03/16/2004US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
03/16/2004US6706712 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2004WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/11/2004US20040048894 Compounds which mimic the chemical and biological properties of discodermolide
03/11/2004US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/11/2004US20040048785 By fibroblasts and/or keratinocytes; particularly hyaluronic acid, and/or proteoglycans
03/10/2004EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
03/10/2004EP1081132B1 Hydroxamic acid derivatives and medicinal utilization thereof
03/09/2004US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder
03/09/2004US6703218 Process for the preparation of linalool oxide or of linalool oxide-containing mixtures
03/04/2004WO2004018414A2 Antibacterial agents
03/04/2004WO2003079996A3 Process for preparing purified s-bel and r-bel and compositions thereof
03/04/2004WO2003000673A3 Process for the preparation of simvastatin
03/04/2004US20040040829 Divided wall structure; rectifier and stripping zone
03/03/2004EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents
03/03/2004EP1392656A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
03/03/2004EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
03/03/2004EP1292555B1 Catalytic hydrogenation of ketones and aldehydes
03/03/2004EP1045839B1 Novel amines as pharmaceutical agents
03/03/2004EP0929217B1 Sordarin derivatives
03/03/2004CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
03/03/2004CN1479712A Ketone compounds and compositions for cholesterol management and related uses
03/02/2004US6700025 Process for stereoselective synthesis of prostacyclin derivatives
03/02/2004US6699910 Ketone compounds and compositions for cholesterol management and related uses
02/2004
02/26/2004WO2004016213A2 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
02/26/2004WO2003097575A3 Amino-functional chalcones
02/26/2004WO2003097574A3 Aminoalkoxy-functional chalcones
02/26/2004WO2002098869A3 1,4-disubstituted benzo-fused cycloalkyl urea compounds
02/26/2004WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
02/26/2004US20040039064 Treating and/or preventing alzheimer's disease and other neurodegenerative diseases; beta-secretase inhibitors
02/26/2004CA2495588A1 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
02/25/2004EP1178986B1 Furanone derivatives as inhibitors of cathepsin s
02/24/2004US6696449 Control degradation of conencting tissue; cardiovascular disorders
02/24/2004US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
02/24/2004US6695969 Displacement chromatography and involves using a displacer for displacing the hmg-coa reductase inhibitor
02/19/2004WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators
02/19/2004US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin
02/19/2004US20040034071 An enzyme inhibitor for matrix metalloprotease
02/19/2004US20040033988 Sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation
02/18/2004CN1476440A Lactonization process
02/17/2004US6693092 Herbicides; pesticides
02/17/2004US6692657 Alkenyl compound with 2,3-difluorophenyl group
02/12/2004WO2004013118A1 Azulene derivatives and salts thereof
02/12/2004WO2004013085A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs
02/12/2004US20040030160 Process for preparation of tetrahydropyranyoxyamines
02/12/2004US20040030054 Quaternary ammonium, phosphonium compound
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 129